Yayın:
New benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorULVİYE, ACAR
dc.contributor.authorÖzkay, Yusuf
dc.contributor.authorKaplacıklı, Zafer Asım
dc.contributor.authorZeynep Deniz Şahin İnan
dc.contributor.authorHayrani Eren Bostancı
dc.contributor.authorYusuf Özkay
dc.contributor.authorZafer Asım Kaplacıklı
dc.contributor.orcid0000-0003-1879-1034
dc.contributor.orcid0000-0002-8146-1663
dc.contributor.orcid0000-0003-2026-2924
dc.contributor.orcid0000-0002-0292-4448
dc.contributor.orcid0000-0001-8511-2316
dc.contributor.orcid0000-0001-8815-153X
dc.date.accessioned2025-11-13T09:51:55Z
dc.date.issued2024-06-01
dc.identifier.doihttps://doi.org/10.1002/ddr.22218
dc.identifier.endpagee22218
dc.identifier.issn0272-4391
dc.identifier.issue4
dc.identifier.openalexW4399295900
dc.identifier.startpagee22218
dc.identifier.urihttps://hdl.handle.net/11421/2425
dc.identifier.urihttps://doi.org/10.1002/ddr.22218
dc.identifier.volume85
dc.language.isoen
dc.relation.ispartofDrug Development Research
dc.rightsopenAccess
dc.subjectBenzimidazole
dc.subjectDocking (animal)
dc.subjectChemistry
dc.subjectCell culture
dc.subjectOxadiazole
dc.subjectIn vitro
dc.subjectVascular endothelial growth factor
dc.subjectKinase insert domain receptor
dc.subjectCell growth
dc.subjectVascular endothelial growth factor A
dc.subjectPharmacology
dc.subjectBiochemistry
dc.subjectVEGF receptors
dc.subjectCancer research
dc.subjectBiology
dc.subjectMedicine
dc.subject.sdg3
dc.titleNew benzimidazole‐oxadiazole derivatives as potent VEGFR‐2 inhibitors: Synthesis, anticancer evaluation, and docking study
dc.typeArticle
dspace.entity.typePublication
local.authorid.openalexA5047270177
local.authorid.openalexA5030511747
local.authorid.openalexA5114172024

Dosyalar

Koleksiyonlar

Publications